Brimonidine 45802-0078
Product NDC
45802-0078- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Gel
- Route
- Topical
- Product Type
- Human Prescription Drug
- Marketing Start
- January 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA209158
Need to source Brimonidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brimonidine Tartrate | 5 mg/g |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Packaging Options(1)
1 BOTTLE, PUMP in 1 CARTON (45802-078-30) / 30 g in 1 BOTTLE, PUMP